Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Drugs Under Experimental and Clinical Research
|
January 1, 1990
Structure-activity relationship of quinolone antibacterial agents: the effects of C-2 substitution
D T Chu, I M Lico, A K Claiborne, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 1, 1987
Regulation of phosphoenolpyruvate carboxykinase gene transcription in H4IIE hepatoma cells: evidence for a primary role of the catalytic subunit of 3',5'-cyclic adenosine monophosphate-dependent protein kinase
S J Beebe, S R Koch, D T Chu, et al.
Journal of Medicinal Chemistry
|
December 1, 1987
Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin)
L A Mitscher, P N Sharma, D T Chu, et al.
Journal of Medicinal Chemistry
|
November 1, 1986
Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents
D T Chu, P B Fernandes, A K Claiborne, et al.
Nucleic Acids Research
|
August 25, 1989
Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity
N B Chrapkiewicz, C M Davis, D T Chu, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1986
In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria
P B Fernandes, N Shipkowitz, R R Bower, et al.
Organic Letters
|
September 15, 2000
Synthesis of 2-fluoro-6-O-propargyl-11,12-carbamate ketolides. A novel class of antibiotics
L T Phan, R F Clark, M Rupp, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1986
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
J M Stamm, C W Hanson, D T Chu, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1986
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
P B Fernandes, D T Chu, R R Bower, et al.
Nature Immunology
|
September 11, 2001
Specific and nonspecific NK cell activation during virus infection
A O Dokun, S Kim, H R Smith, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Drugs Under Experimental and Clinical Research
|
January 1, 1990
Structure-activity relationship of quinolone antibacterial agents: the effects of C-2 substitution
D T Chu, I M Lico, A K Claiborne, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 1, 1987
Regulation of phosphoenolpyruvate carboxykinase gene transcription in H4IIE hepatoma cells: evidence for a primary role of the catalytic subunit of 3',5'-cyclic adenosine monophosphate-dependent protein kinase
S J Beebe, S R Koch, D T Chu, et al.
Journal of Medicinal Chemistry
|
December 1, 1987
Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin)
L A Mitscher, P N Sharma, D T Chu, et al.
Journal of Medicinal Chemistry
|
November 1, 1986
Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents
D T Chu, P B Fernandes, A K Claiborne, et al.
Nucleic Acids Research
|
August 25, 1989
Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity
N B Chrapkiewicz, C M Davis, D T Chu, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1986
In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria
P B Fernandes, N Shipkowitz, R R Bower, et al.
Organic Letters
|
September 15, 2000
Synthesis of 2-fluoro-6-O-propargyl-11,12-carbamate ketolides. A novel class of antibiotics
L T Phan, R F Clark, M Rupp, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1986
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
J M Stamm, C W Hanson, D T Chu, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1986
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
P B Fernandes, D T Chu, R R Bower, et al.
Nature Immunology
|
September 11, 2001
Specific and nonspecific NK cell activation during virus infection
A O Dokun, S Kim, H R Smith, et al.
Page
of 9